0000950170-24-066215.txt : 20240529 0000950170-24-066215.hdr.sgml : 20240529 20240529211200 ACCESSION NUMBER: 0000950170-24-066215 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240523 FILED AS OF DATE: 20240529 DATE AS OF CHANGE: 20240529 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Seelenberger Alexander A. CENTRAL INDEX KEY: 0001832562 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39244 FILM NUMBER: 241000504 MAIL ADDRESS: STREET 1: 4500 GREAT AMERICA PKWY STREET 2: STE. 100 #29 CITY: SANTA CLARA STATE: CA ZIP: 95054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vincerx Pharma, Inc. CENTRAL INDEX KEY: 0001796129 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 833197402 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 260 SHERIDAN AVENUE STREET 2: SUITE 400 CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 650-800-6676 MAIL ADDRESS: STREET 1: 260 SHERIDAN AVENUE STREET 2: SUITE 400 CITY: PALO ALTO STATE: CA ZIP: 94306 FORMER COMPANY: FORMER CONFORMED NAME: Vincera Pharma, Inc. DATE OF NAME CHANGE: 20201223 FORMER COMPANY: FORMER CONFORMED NAME: LifeSci Acquisition Corp. DATE OF NAME CHANGE: 20191206 4 1 ownership.xml 4 X0508 4 2024-05-23 0001796129 Vincerx Pharma, Inc. VINC 0001832562 Seelenberger Alexander A. 260 SHERIDAN AVENUE, SUITE 400 PALO ALTO CA 94306 false true false false Chief Financial Officer false Stock Option (right to buy) 7.38 2024-05-23 4 A false 31250 0.00 A 2034-03-06 Common Stock 31250 125000 D The option grant was approved on March 7, 2024, subject to stockholder approval of an amendment to the Vincerx Pharma, Inc. 2020 Stock Incentive Plan. The stockholders approved the amendment on May 23, 2024. One-third (1/3) vests on March 7, 2025, with the remainder vesting in twenty-four equal monthly installments thereafter. By: /s/ Dr. Ahmed M. Hamdy, attorney-in-fact 2024-05-29